Skip to main content

Trinity Biotech PLC

TRIB
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
SEC CIK
0000888721

No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Trinity Biotech PLC changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of TRIB: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders27123−3
Shares849.8K2221.07M+223.5K (+26.3%)
Value$673.3K$176$588.9K−$84.2K (−12.5%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (5)

Institutions that held Trinity Biotech PLC at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to TRIB in Q1 2026
InstitutionSharesValue% of portfolio
Yorkville Advisors Global, LP225,000$122.0K0.08%
Virtu Financial LLC26,676$14.0K0.00%
Wells Fargo & Company2,500$1.36K0.00%
Simplex Trading, LLC555$3000.00%
McIlrath & Eck, LLC5$30.00%

Sold out (8)

Institutions that held Trinity Biotech PLC at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of TRIB in Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Two Sigma Investments, LP18,650$14.8K
Two Sigma Securities, LLC15,797$12.5K
Susquehanna International Group, LLP14,249$11.3K
Advisor Group Holdings, Inc.2,500$1.98K
Royal Bank of Canada1,000$1.00K
Bank of America Corp1,095$867
National Bank of Canada1,000$791
FMR LLC11$9

Not filed for Q1 2026 yet (1)

Institutions that held Trinity Biotech PLC at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TRIB in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
CIBC Private Wealth Group, LLC222$176